1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What Is This Report About?

3 Definitions of the Markets Covered in the Report
3.1 Diabetes Care Devices
3.2 Glucose Monitoring
3.2.1 Blood Glucose Meter
3.2.2 Blood Glucose Strips
3.3 Insulin Delivery
3.3.1 Insulin Pen
3.3.2 Insulin Pump
3.3.3 Insulin Syringes

4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
4.3.1 Health Insurance Act
4.3.2 Healthcare Allowance Act
4.3.3 The Exceptional Medical Expenses Act

5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification of Medical Devices
5.1.2 Conformity Assessment Process
5.1.2.1 Class I devices
5.1.2.2 Class IIa devices
5.1.2.3 Class IIb devices
5.1.2.4 Class III devices
5.2 Post Market Surveillance (PMS)

6 Pricing and Reimbursement
6.1 Pricing and Reimbursement in Netherlands

7 Distribution Structure
7.1 Distribution Structure in Netherlands

8 Diabetes Care Devices In Netherlands
8.1 Diabetes Care Devices Cross Country Comparison (2000-2012)
8.2 Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), 2000-2012
8.3 Diabetes Care Devices, Netherlands, Category Volume (Units), 2000-2012
8.4 Diabetes Care Devices, Netherlands Company share (2006-2007)

9 Glucose Monitoring In Netherlands
9.1 Glucose Monitoring Overall Revenue (2000-2012)
9.2 Glucose Monitoring Overall Volume (2000-2012)
9.3 Glucose Monitoring Average Price (2000-2012)
9.4 Glucose Monitoring Distribution Share (2006-2007)
9.5 Glucose Monitoring, Netherlands, Company Share (2006-2007)

10 Insulin Delivery In Netherlands
10.1 Insulin Delivery Overall Revenue (2000-2012)
10.2 Insulin Delivery Overall Volume (2000-2012)
10.3 Insulin Delivery Average Price (2000-2012)
10.4 Insulin Delivery Distribution Share (2006-2007)
10.5 Insulin Delivery, Netherlands, Company Share (2006-2007)

11 F. Hoffmann-La Roche Ltd. Company Profile
11.1 Company Overview
11.2 Value Chain Analysis
11.2.1 Manufacturing
11.2.1.1 In House Manufacturing
11.2.1.2 Outsourcing
11.2.2 Product Development
11.2.2.1 Regulatory Approvals
11.2.2.2 Clinical Trials
11.2.2.3 Research and Development
11.2.3 Sales and Marketing
11.2.3.1 Partnerships and Alliances
11.2.3.2 Licensing Agreements

12 LifeScan, Inc. Company Profile
12.1 Company Overview
12.1.1 LifeScan, Inc. Pipeline Products by Equipment Type
12.1.2 LifeScan, Inc. Pipeline Products by Development Stage
12.1.3 LifeScan, Inc. Pipeline Products By Therapy Area
12.1.4 LifeScan, Inc. Pipeline Products By Clinical Trials
12.1.5 LifeScan, Inc. Pipeline Products By News Summary

13 Bayer HealthCare AG Company Profile
13.1 Company Overview
13.2 Value Chain Analysis
13.2.1 Manufacturing
13.2.1.1 In House Manufacturing
13.2.1.2 Outsourcing
13.2.2 Product Development
13.2.2.1 Regulatory Approvals
13.2.2.2 Clinical Trials
13.2.2.3 Research and Development
13.2.3 Sales and Marketing
13.2.3.1 Partnerships and Alliances
13.2.3.2 Licensing Agreements
13.3 Bayer HealthCare AG Pipeline Products

1.1 List of Tables

Table 1: Doctors by Specialty in Netherlands, 2000-2006
Table 2: Hospital Wards by Type in Netherlands, 2000-2006
Table 3: Diabetes Care Devices Cross Country Comparison (2000-2012)
Table 4: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), 2000-2012
Table 5: Diabetes Care Devices, Egypt, Portfolio Analysis, 2000-2012
Table 6: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
Table 7: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
Table 8: Diabetes Care Devices, Netherlands, Category Volume (Units), 2000-2012
Table 9: Diabetes Care Devices, Netherlands, Category Volume (Units), Historic, 2000-2007
Table 10: Diabetes Care Devices, Netherlands, Category Volume (Units), Forecast, 2007-2012
Table 11: Diabetes Care Devices, Netherlands Company share by Revenue ($ mn), 2006-2007
Table 12: Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment , Historic, 2000-2007
Table 13: Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment , Forecast, 2007-2012
Table 14: Glucose Monitoring, Netherlands, Overall Volume (Units), Historic, 2000-2007
Table 15: Glucose Monitoring, Netherlands, Overall Volume (Units), Forecast, 2007-2012
Table 16: Glucose Monitoring, Netherlands, Average Price ($), Historic, 2000-2007
Table 17: Glucose Monitoring, Netherlands, Average Price ($), Forecast,, 2007-2012
Table 18: Glucose Monitoring, Netherlands, Distribution Share by Revenue ($mn), 2006-2007
Table 19: Glucose Monitoring, Netherlands, Company Share by Revenue ($ mn), 2006-2007
Table 20: Insulin Delivery, Netherlands, Revenue ($ mn) by Segment , Historic, 2000-2007
Table 21: Insulin Delivery, Netherlands, Revenue ($ mn) by Segment , Forecast, 2007-2012
Table 22: Insulin Delivery, Netherlands, Overall Volume (Units), Historic, 2000-2007
Table 23: Insulin Delivery, Netherlands, Overall Volume (Units), Forecast, 2007-2012
Table 24: Insulin Delivery, Netherlands, Average Price ($), Historic, 2000-2007
Table 25: Insulin Delivery, Netherlands, Average Price ($), Forecast,, 2007-2012
Table 26: Insulin Delivery, Netherlands, Distribution Share by Revenue ($mn), 2006-2007
Table 27: Insulin Delivery, Netherlands, Company Share by Revenue ($ mn), 2006-2007
Table 28: LifeScan, Inc. Pipeline Products by Equipment Type
Table 29: LifeScan, Inc. Pipeline Products by Development Stage
Table 30: LifeScan, Inc. Pipeline Products By Therapy Area
Table 31: LifeScan, Inc. Pipeline Products By Clinical Trials
Table 32: LifeScan, Inc. Pipeline Products By News Summaries
Table 33: Bayer HealthCare AG Pipeline Products by Equipment Type
Table 34: Bayer HealthCare AG Pipeline Products By Development Stage
Table 35: Bayer HealthCare AG Pipeline Products By Therapy Area
Table 36: Bayer HealthCare AG Pipeline Products By News Summaries
Table 37: Novo Nordisk A/S Pipeline Products by Equipment Type
Table 38: Novo Nordisk A/S Pipeline Products By Development Stage
Table 39: Novo Nordisk A/S Pipeline Products By Therapy Area
Table 40: Novo Nordisk A/S Pipeline Products By Clinical Trials
Table 41: Abbott Laboratories Pipeline Products by Equipment Type
Table 42: Abbott Laboratories Pipeline Products By Development Stage
Table 43: Abbott Laboratories Pipeline Products By Therapy Area
Table 44: Abbott Laboratories Pipeline Products By Clinical Trials
Table 45: Abbott Laboratories Pipeline Products By News Summaries
Table 46: Eli Lilly and Company Pipeline Products by Equipment Type
Table 43: Eli Lilly and Company Pipeline Products by Development Stage
Table 47: Eli Lilly and Company Pipeline Products By Therapy Area
Table 48: Currency Conversion from USD to Local Currency at 2007 Constant Rate

1.2 List of Figures

Figure 1: Total Healthcare Expenditure in Netherlands, 2000 - 2006
Figure 2: Healthcare Financing Framework in Netherlands, 2005
Figure 3: Flowchart for Classification of Non-invasive Devices in Netherlands, 2007
Figure 4: Flowchart for Classification of Invasive Devices in Netherlands, 2007
Figure 5: Flowchart for Classification of Invasive Devices in Netherlands, 2007
Figure 6: Flowchart for Classification of Invasive Devices in Netherlands, 2007
Figure 7: Flowchart for Classification of Invasive Devices in Netherlands, 2007
Figure 8: Flowchart for Classification of Active Devices in Netherlands, 2007
Figure 9: Flowchart for Classification of Active Devices in Netherlands, 2007
Figure 10: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Netherlands, 2007
Figure 11: Conformity Assessment of Class-I Medical Devices in Netherlands, 2007
Figure 12: Conformity Assessment of Class-IIa Medical Devices in Netherlands, 2007
Figure 13: Conformity Assessment of Class-IIb Medical Devices in Netherlands, 2007
Figure 14: Conformity Assessment of Class-III Medical Devices in Netherlands, 2007
Figure 15: Diabetes Care Devices Cross Country Comparison (2000-2012)
Figure 16: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), 2000-2012
Figure 17: Diabetes Care Devices, Egypt, Portfolio Analysis, 2000-2012
Figure 18: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
Figure 19: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 20: Diabetes Care Devices, Netherlands, Category Volume (Units), 2000-2012
Figure 21: Diabetes Care Devices, Netherlands, Category Volume (Units), Historic, 2000-2007
Figure 22: Diabetes Care Devices, Netherlands, Category Volume (Units), Forecast, 2007-2012
Figure 23: Diabetes Care Devices, Netherlands Company share (%), 2007
Figure 24: Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment , Historic, 2000-2007
Figure 25: Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment , Forecast, 2007-2012
Figure 26: Glucose Monitoring, Netherlands, Overall Volume (Units), Historic, 2000-2007
Figure 27: Glucose Monitoring, Netherlands, Overall Volume (Units), Forecast, 2007-2012
Figure 28: Glucose Monitoring, Netherlands, Company Share (%), 2007
Figure 29: Insulin Delivery, Netherlands, Revenue ($ mn) by Segment , Historic, 2000-2007
Figure 30: Insulin Delivery, Netherlands, Revenue ($ mn) by Segment , Forecast, 2007-2012
Figure 31: Insulin Delivery, Netherlands, Company Share (%), 2007
Figure 32: F. Hoffmann-La Roche Ltd Value Chain Analysis
Figure 33: Bayer HealthCare AG Value Chain Analysis
Figure 34: Abbott Laboratories Value Chain Analysis
Figure 35: Eli Lilly and Company Value Chain Analysis
Figure 36: Global Markets Direct Methodology